Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Sonoma Pharmaceuticals (SNOA)
NASDAQ:SNOA
RESEARCH TOOLSreports
Holding SNOA?
Track your performance easily
SNOA Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.31 - $18.98
Previous Close$4.21
Volume2.39M
Average Volume (3M)200.62K
Market Cap
$4.32M
Enterprise Value$2.15M
Total Cash (Recent Filing)$2.59M
Total Debt (Recent Filing)$420.00K
Price to Earnings (P/E)―
Beta2.83
Next Earnings
Nov 11, 2024EPS Estimate
-$0.9Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-10.04
Shares Outstanding1,025,735
10 Day Avg. Volume314,660
30 Day Avg. Volume200,621
Standard Deviation0.26
R-Squared0.08
Alpha-0.04
Financial Highlights & Ratios
Price to Book (P/B)1.07
Price to Sales (P/S)0.34
Price to Cash Flow (P/CF)-1.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.17
Enterprise Value/Gross Profit0.45
Enterprise Value/Ebitda-0.50
Forecast
1Y Price Target
$1.50Price Target Upside-71.15% Downside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Sonoma Pharmaceuticals News
PremiumCompany Announcements
Sonoma Pharmaceuticals Stockholders Decide on Key Governance Issues
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
SNOA FAQ
What was Sonoma Pharmaceuticals’s price range in the past 12 months?
Sonoma Pharmaceuticals lowest stock price was $2.31 and its highest was $18.98 in the past 12 months.
What is Sonoma Pharmaceuticals’s market cap?
Currently, no data Available
When is Sonoma Pharmaceuticals’s upcoming earnings report date?
Sonoma Pharmaceuticals’s upcoming earnings report date is Nov 11, 2024 which is in 52 days.
How were Sonoma Pharmaceuticals’s earnings last quarter?
Sonoma Pharmaceuticals released its earnings results on Jun 17, 2024. The company reported -$1.378 earnings per share for the quarter, missing the consensus estimate of N/A by -$1.378.
Is Sonoma Pharmaceuticals overvalued?
According to Wall Street analysts Sonoma Pharmaceuticals’s price is currently Overvalued.
Does Sonoma Pharmaceuticals pay dividends?
Sonoma Pharmaceuticals does not currently pay dividends.
What is Sonoma Pharmaceuticals’s EPS estimate?
Sonoma Pharmaceuticals’s EPS estimate is -$0.9.
How many shares outstanding does Sonoma Pharmaceuticals have?
Sonoma Pharmaceuticals has 1,025,735 shares outstanding.
What happened to Sonoma Pharmaceuticals’s price movement after its last earnings report?
Sonoma Pharmaceuticals reported an EPS of -$1.378 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 13.947%.
Which hedge fund is a major shareholder of Sonoma Pharmaceuticals?
Currently, no hedge funds are holding shares in SNOA
---
Sonoma Pharmaceuticals Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$1.50 (-71.15% Downside)
$1.50 (-71.15% Downside)
Crowd Wisdom
Very Positive
Last 7 Days ▼ 1.4%
Last 30 Days ▲ 11.7%
Last 30 Days ▲ 11.7%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-77.79%
12-Months-Change
Fundamentals
Return on Equity
-74.65%
Trailing 12-Months
Asset Growth
-13.97%
Trailing 12-Months
Company Description
Sonoma Pharmaceuticals
Sonoma Pharmaceuticals, Inc. engages in identifying, developing, and commercializing therapies for chronic skin conditions. The company offers solutions in dermatology, animal healthcare, and advanced tissue care product areas. Its products target skin diseases including acne, atopic dermatitis, scarring, infections, itch, pain, and harmful inflammatory responses. The company was founded by Hojabr Alimi and Linda Alimi in April 1999 and is headquartered in Petaluma, CA.
---
SNOA Stock 12 Month Forecast
Average Price Target
$1.50
▼(-71.15% Downside)
Technical Analysis
Best Analysts Covering SNOA
1 Year
1 Year Success Rate
1/2 ratings generated profit
1 Year Average Return
-36.45%
reiterated a buy rating 3 months ago
Copying Jeffrey Cohen's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of -36.45% per trade.
---